Items where Author is "Naci, Huseyin"

Forrest, Robin, Lagarde, Mylene ORCID: 0000-0002-5713-2659, Aggarwal, Ajay and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2024) Preferences for speed of access versus certainty of the survival benefit of new cancer drugs: a discrete choice experiment. The Lancet Oncology, 25 (12). 1635 - 1643. ISSN 1470-2045

Naci, Huseyin ORCID: 0000-0002-7192-5751, Murphy, Peter, Woods, Beth, Lomas, James, Wei, Jinru and Papanicolas, Irene ORCID: 0000-0002-8000-3185 (2024) Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000–20: a retrospective analysis. The Lancet. ISSN 0140-6736

Lythgoe, Mark P., Emhardt, Alica Joana, Naci, Huseyin ORCID: 0000-0002-7192-5751, Krell, Jonathan, Sullivan, Richard and Aggarwal, Ajay (2024) Efficacy and safety of interim oncology treatments introduced for solid cancers during the COVID-19 pandemic in England: a retrospective evidence-based analysis. The Lancet Regional Health - Europe, 46. ISSN 2666-7762

Soumerai, Stephen B., Koppel, Ross, Naci, Huseyin ORCID: 0000-0002-7192-5751, Madden, Jeanne M., Fry, Andra, Halbisen, Alyssa, Angeles, Jesenia, Koppel, Jonah, Rubin, Rachelle and Lu, Christine Y. (2024) Intended and unintended outcomes after FDA pediatric antidepressant warnings: a systematic review. Health affairs (Project Hope), 43 (10). 1360 - 1369. ISSN 0278-2715

Davis, Courtney, Wagner, Anita K., Mintzes, Barbara, Scowcroft, Henry, Woloshin, Steven and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2024) Patients deserve better information on new drugs. BMJ (Clinical research ed.), 387. ISSN 0959-8146

Salcher-Konrad, Maximilian ORCID: 0000-0002-5628-5266, Nguyen, Mary, Savović, Jelena, Higgins, Julian P. T. and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2024) Treatment effects in randomized and nonrandomized studies of pharmacological interventions: a meta-analysis. JAMA network open, 7 (9). ISSN 2574-3805

Tinelli, Michela ORCID: 0000-0002-8816-4389, Athanasiou, Antonios, Veroniki, Areti angeliki, Efthimiou, Orestis, Kalliala, Ilkka, Bowden, Sarah, Paraskevaidi, Maria, Lyons, Deirdre, Martin‐hirsch, Pierre, Bennett, Phillip, Paraskevaidis, Evangelos, Salanti, Georgia, Kyrgiou, Maria and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2024) Treatment methods for cervical intraepithelial neoplasia in England: a cost‐effectiveness analysis. BJOG: An International Journal of Obstetrics and Gynaecology, 131 (10). 1411 - 1419. ISSN 1470-0328

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Papanicolas, Irene ORCID: 0000-0002-8000-3185 (2024) Health Technology Assessment in the US—a word of caution—reply. JAMA Internal Medicine, 184 (7). 851 - 851. ISSN 2168-6106

Shahzad, Mahnum, Naci, Huseyin ORCID: 0000-0002-7192-5751, Esselen, Katharine M., Dottino, Joseph A. and Wagner, Anita K. (2024) Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathway. Journal of Pharmaceutical Policy and Practice, 17 (1). ISSN 2052-3211

Naci, Huseyin ORCID: 0000-0002-7192-5751, Zhang, Yichen, Woloshin, Steven, Guan, Xiaodong, Xu, Ziyue and Wagner, Anita K. (2024) Overall survival benefits of cancer drugs initially approved by the US Food and Drug Administration on the basis of immature survival data: a retrospective analysis. The Lancet Oncology, 25 (6). 760 - 769. ISSN 1470-2045

Wei, Yuxuan, Zhang, Yichen, Xu, Ziyue, Wang, Guoan, Zhou, Yue, Li, Huangqianyu, Shi, Luwen, Naci, Huseyin ORCID: 0000-0002-7192-5751, Wagner, Anita K. and Guan, Xiaodong (2024) Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001–2020. The Lancet Regional Health - Western Pacific, 45. ISSN 2666-6065

Swift, Bethan, Taneri, Bahar, Becker, Christian M., Basarir, Hasan, Naci, Huseyin ORCID: 0000-0002-7192-5751, Missmer, Stacey A., Zondervan, Krina T. and Rahmioglu, Nilufer (2024) Prevalence, diagnostic delay and economic burden of endometriosis and its impact on quality of life: results from an Eastern Mediterranean population. European Journal of Public Health, 34 (2). 244 - 252. ISSN 1101-1262

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Papanicolas, Irene ORCID: 0000-0002-8000-3185 (2024) Availability and coverage of new drugs in 6 high-income countries with health technology assessment bodies. Journal of American Medical Association: Internal Medicine, 184 (3). 328 - 330. ISSN 2168-6106

Zhou, Yue, Naci, Huseyin ORCID: 0000-0002-7192-5751, Chen, Dingyi, Bai, Lin, Shi, Luwen, Guan, Xiaodong and Wagner, Anita Katharina (2023) Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015–2021. BMJ Global Health, 8 (9). ISSN 2059-7908

Salcher-Konrad, Maximilian ORCID: 0000-0002-5628-5266, Shi, Cheng, Patel, Disha, McDaid, David ORCID: 0000-0003-0744-2664, Iveth Astudillo García, Claudia, Bobrow, Kirsten, Choy, Jacky C.P., Comas-Herrera, Adelina ORCID: 0000-0002-9860-9062, Fry, Andra, Knapp, Martin ORCID: 0000-0003-1427-0215, Leung, Dara K.Y., Lopez-Ortega, Mariana, Lorenz, Klara, Musyimi, Christina, Ndetei, David, Nguyen, Tuan A., Oliveira, Deborah, Putra, Aditya, Vara, Alisha, Wong, Gloria H.Y. and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2023) Research evaluating the effectiveness of dementia interventions in low- and middle-income countries: a systematic mapping of 340 randomised controlled trials. International Journal of Geriatric Psychiatry, 38 (7). ISSN 0885-6230

Ivama-Brummell, Adriana M., Marciniuk, Fernanda L, Wagner, Anita K., Osorio-de-Castro, Claudia G. S., Vogler, Sabine, Mossialos, Elias ORCID: 0000-0001-8664-9297, Tavares-de-Andrade, Carla L. and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2023) Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysis. The Lancet Regional Health - Americas, 22. ISSN 2667-193X

Parvanova, Iva, Gentilini, Arianna, Cushing, Jonathan and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2023) Safeguarding NICE from patient groups' conflicts of interest. BMJ, 381. ISSN 0959-8146

Forrest, Robin and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2023) Prioritising patients in negotiations over drug pricing. BMJ (Clinical research ed.), 381. ISSN 1756-1833

Cherla, Avi, Davis, Courtney, Mossialos, Elias ORCID: 0000-0001-8664-9297 and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2023) Faster UK drug approvals by relying on other countries. BMJ (Clinical research ed.), 381. p. 739. ISSN 1756-1833

Davis, Courtney, Wagner, Anita K., Salcher-Konrad, Maximilian ORCID: 0000-0002-5628-5266, Scowcroft, Henry, Mintzes, Barbara, Pokorny, Adrian M J, Lew, Jianhui and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2023) Communication of anticancer drug benefits and related uncertainties to patients and clinicians: document analysis of regulated information on prescription drugs in Europe. BMJ, 380. e073711. ISSN 0959-8138

Shahzad, Mahnum, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Wagner, Anita K. (2023) Association between preapproval confirmatory trial initiation and conversion to traditional approval or withdrawal in the FDA accelerated approval pathway. JAMA, 329 (9). 760 - 761. ISSN 0098-7484

Naci, Huseyin ORCID: 0000-0002-7192-5751, Forrest, Robin, Zhai, Mike, Stofesky, Amanda R. and Kesselheim, Aaron S. (2023) Characteristics of prior authorization policies for new drugs in Medicare Part D. JAMA Health Forum, 4 (2). ISSN 2689-0186

Vokinger, Kerstin N. and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2022) Negotiating drug prices in the US - lessons from Europe. JAMA Health Forum, 3 (12). ISSN 2689-0186

Ostinelli, Edoardo Giuseppe, Efthimiou, Orestis, Naci, Huseyin ORCID: 0000-0002-7192-5751, Furukawa, Toshi A., Leucht, Stefan, Salanti, Georgia, Wainwright, Laurence, Zangani, Caroline, De Crescenzo, Franco, Smith, Katharine, Stevens, Katherine, Liu, Qiang and Cipriani, Andrea (2022) Vitruvian plot: a visualisation tool for multiple outcomes in network meta-analysis. Evidence-Based Mental Health, 25 (e1). e65 - e70. ISSN 1362-0347

Carl, David L., Laube, Yannic, Serra-Burriel, Miquel, Naci, Huseyin ORCID: 0000-0002-7192-5751, Ludwig, Wolf Dieter and Vokinger, Kerstin N. (2022) Comparison of uptake and prices of biosimilars in the US, Germany, and Switzerland. JAMA network open, 5 (12). ISSN 2574-3805

Cherla, Avi, Mossialos, Elias ORCID: 0000-0001-8664-9297, Salcher-Konrad, Maximilian ORCID: 0000-0002-5628-5266, Kesselheim, Aaron S. and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2022) Post-marketing requirements for cancer drugs approved by the European Medicines Agency, 2004-2014. Clinical Pharmacology and Therapeutics, 112 (4). 846 - 852. ISSN 0009-9236

Blankart, Katharina, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Chandra, Amitabh (2022) Availability of new medicines in the US and Germany from 2004 to 2018. JAMA network open, 5 (8). ISSN 2574-3805

Zhang, Yichen, Naci, Huseyin ORCID: 0000-0002-7192-5751, Wagner, Anita K., Xu, Ziyue, Yang, Yu, Zhu, Jun, Ji, Jiafu, Shi, Luwen and Guan, Xiaodong (2022) Overall survival benefits of cancer drugs approved in China from 2005 to 2020. JAMA network open, 5 (8). ISSN 2574-3805

Athanasiou, Antonios, Veroniki, Areti Angeliki, Efthimiou, Orestis, Kalliala, Ilkka, Naci, Huseyin ORCID: 0000-0002-7192-5751, Bowden, Sarah, Paraskevaidi, Maria, Arbyn, Marc, Lyons, Deirdre, Martin-Hirsch, Pierre, Bennett, Phillip, Paraskevaidis, Evangelos, Salanti, Georgia and Kyrgiou, Maria (2022) Comparative effectiveness and risk of preterm birth of local treatments for cervical intraepithelial neoplasia and stage IA1 cervical cancer: a systematic review and network meta-analysis. The Lancet Oncology, 23 (8). 1097 - 1108. ISSN 1470-2045

Costa, Suzete, Romão, Mariana, Mendes, Maria, Horta, Maria Rute, Rodrigues, António Teixeira, Carneiro, António Vaz, Martins, Ana Paula, Mallarini, Erika, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Babar, Zaheer Ud Din (2022) Pharmacy interventions on COVID-19 in Europe: mapping current practices and a scoping review. Research in Social and Administrative Pharmacy, 18 (8). 3338 - 3349. ISSN 1551-7411

Naci, Huseyin ORCID: 0000-0002-7192-5751, Kyriopoulos, Ilias-Ioannis ORCID: 0000-0002-3932-8228, Feldman, William B., Hwang, Thomas J., Kesselheim, Aaron S. and Chandra, Amitabh (2022) Coverage of new drugs in Medicare Part D. Milbank Quarterly, 100 (2). 562 - 588. ISSN 0887-378X

Kapelios, Chris J., Naci, Huseyin ORCID: 0000-0002-7192-5751, Vardas, Panos E. and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2022) Study design, result posting, and publication of late-stage cardiovascular trials. European heart journal. Quality of care & clinical outcomes, 8 (3). 277 - 288. ISSN 2058-1742

Vokinger, Kerstin N., Hwang, Thomas J., Carl, David L., Laube, Yannic, Ludwig, Wolf Dieter, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Kesselheim, Aaron S. (2022) Price changes and within-class competition of cancer drugs in the USA and Europe: a comparative analysis. The Lancet Oncology, 23 (4). 514 - 520. ISSN 1470-2045

Bartholomew, Theodore, Naci, Huseyin ORCID: 0000-0002-7192-5751, Robertson, Emma and Schmidt, Harald (2022) Use of adherence monitoring in drug contracts tied to outcomes: put patients first. BMJ (Clinical research ed.), 376. ISSN 1756-1833

Fu, Mengyuan, Naci, Huseyin ORCID: 0000-0002-7192-5751, Booth, Christopher M., Gyawali, Bishal, Cosgrove, Austin, Toh, Sengwee, Xu, Ziyue, Guan, Xiaodong, Ross-Degnan, Dennis and Wagner, Anita K. (2021) Real-world use of and spending on new oral targeted cancer Drugs in the US, 2011-2018. JAMA Internal Medicine, 181 (12). 1596 - 1604. ISSN 2168-6106

Naci, Huseyin ORCID: 0000-0002-7192-5751, Guan, Xiaodong, Woloshin, Steven, Xu, Ziyue and Wagner, Anita K. (2021) Communication of survival data in US Food and Drug Administration-approved labeling of cancer drugs. JAMA Internal Medicine, 181 (11). 1521 - 1522. ISSN 2168-6106

Dawoud, Dalia, Naci, Huseyin ORCID: 0000-0002-7192-5751, Ciani, Oriana and Bujkiewicz, Sylwia (2021) Raising the bar for using surrogate endpoints in drug regulation and health technology assessment. The BMJ, 374. ISSN 0959-8146

Cherla, Avi, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2021) The coverage in England of US-approved cancer drugs reply: in reply. JAMA Internal Medicine, 181 (9). 1263 - 1264. ISSN 2168-6106

Beirne, Anne Marie, Mitchelmore, Oliver, Palma, Susana, Andiapen, Mervyn, Rathod, Krishnaraj S., Hammond, Victoria, Bellin, Anna, Cooper, Jackie, Wright, Paul, Antoniou, Sotiris, Yaqoob, Muhammad Magdi, Naci, Huseyin ORCID: 0000-0002-7192-5751, Mathur, Anthony, Ahluwalia, Amrita and Jones, Daniel A. (2021) NITRATE-CIN Study: Protocol of a Randomized (1:1) Single-Center, UK, Double-Blind Placebo-Controlled Trial Testing the Effect of Inorganic Nitrate on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography for Acute Coronary Syndromes. Journal of Cardiovascular Pharmacology and Therapeutics, 26 (4). pp. 303-309. ISSN 1074-2484

Cherla, Avi, Naci, Huseyin ORCID: 0000-0002-7192-5751, Kesselheim, Aaron S., Gyawali, Bishal and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2021) Assessment of coverage in England of cancer drugs qualifying for US food and drug administration accelerated approval. JAMA Internal Medicine, 181 (4). 490 - 498. ISSN 2168-6106

Petersen, Steffen E., Friebel, Rocco ORCID: 0000-0003-1256-9096, Ferrari, Victor, Han, Yuchi, Aung, Nay, Kenawy, Asmaa, Albert, Timothy S.E. and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2021) Recent trends and potential drivers of non-invasive cardiovascular imaging use in the United States of America and England. Frontiers in Cardiovascular Medicine, 7. ISSN 2297-055X

Salcher-Konrad, Maximilian ORCID: 0000-0002-5628-5266, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Davis, Courtney (2020) Approval of cancer drugs with uncertain therapeutic value: a comparison of regulatory decisions in Europe and the United States. Milbank Quarterly, 98 (4). 1219 - 1256. ISSN 0887-378X

Angelis, Aris ORCID: 0000-0002-0261-4634, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Hackshaw, Allan (2020) Recalibrating health technology assessment methods for cell and gene therapies. PharmacoEconomics, 38 (12). pp. 1297-1308. ISSN 1170-7690

Naci, Huseyin ORCID: 0000-0002-7192-5751, Kesselheim, Aaron S., Rttingen, John Arne, Salanti, Georgia, Vandvik, Per O. and Cipriani, Andrea (2020) Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19. The BMJ, 371. ISSN 0959-8146

Salcher-Konrad, Maximilian ORCID: 0000-0002-5628-5266 and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2020) Unintended consequences of coverage laws targeting cancer drugs. Journal of Law, Medicine and Ethics, 48 (3). pp. 552-554. ISSN 1073-1105

Vreman, Rick A., Naci, Huseyin ORCID: 0000-0002-7192-5751, Goettsch, Wim G., Mantel-Teeuwisse, Aukje K., Schneeweiss, Sebastian G., Leufkens, Hubert G.M. and Kesselheim, Aaron S. (2020) Decision making under uncertainty: comparing regulatory and health technology assessment reviews of medicines in the United States and Europe. Clinical Pharmacology and Therapeutics, 108 (2). pp. 350-357. ISSN 0009-9236

Naci, Huseyin ORCID: 0000-0002-7192-5751 and Kesselheim, Aaron S. (2020) Specialty drugs: a distinctly American phenomenon. New England Journal of Medicine, 382 (23). 2179 - 2181. ISSN 0028-4793

Singh, Ilina, Naci, Huseyin ORCID: 0000-0002-7192-5751, Miller, Jennifer, Caplan, Arthur and Cipriani, Andrea (2020) Ethical implications of poor comparative effectiveness evidence: obligations in industry-research partnerships. The Lancet, 395 (10228). 926 - 928. ISSN 0140-6736

Cipriani, Andrea, Ioannidis, John P.A., Rothwell, Peter M., Glasziou, Paul, Li, Tianjing, Hernandez, Adrian F., Tomlinson, Anneka, Simes, John and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2020) Generating comparative evidence on new drugs and devices after approval. The Lancet, 395 (10228). pp. 998-1010. ISSN 0140-6736

Naci, Huseyin ORCID: 0000-0002-7192-5751, Salcher-Konrad, Maximilian ORCID: 0000-0002-5628-5266, Kesselheim, Aaron S., Dr.rer.nat, Beate Wiesler, Rochaix, Lise, Redberg, Rita, Salanti, Georgia, Jackson, Emily, Garner, Sarah, Stroup, Scott and Cipriani, Andrea (2020) Generating comparative evidence on new drugs and devices before approval. The Lancet, 395 (10228). 986 - 997. ISSN 0140-6736

Pinto, Ashlyn, Naci, Huseyin ORCID: 0000-0002-7192-5751, Neez, Emilie and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2020) Association between the use of surrogate measures in pivotal trials and health technology assessment decisions: a retrospective analysis of NICE and CADTH reviews of cancer drugs. Value in Health, 23 (3). pp. 319-327. ISSN 1098-3015

Aung, Nay, Doimo, Sara, Ricci, Fabrizio, Sanghvi, Mihir M., Pedrosa, Cesar, Woodbridge, Simon P., Al-Balah, Amer, Zemrak, Filip, Khanji, Mohammed Y., Munroe, Patricia B., Naci, Huseyin ORCID: 0000-0002-7192-5751 and Petersen, Steffen E. (2020) Prognostic significance of left ventricular noncompaction: systematic review and meta-analysis of observational studies. Circulation: Cardiovascular Imaging, 13 (1). ISSN 1941-9651

Athanasiou, Antonios, Veroniki, Areti Angeliki, Efthimiou, Orestis, Kalliala, Ilkka, Naci, Huseyin ORCID: 0000-0002-7192-5751, Bowden, Sarah, Paraskevaidi, Maria, Martin-Hirsch, Pierre, Bennett, Philip, Paraskevaidis, Evangelos, Salanti, Georgia and Kyrgiou, Maria (2019) Comparative fertility and pregnancy outcomes after local treatment for cervical intraepithelial neoplasia and stage 1a1 cervical cancer: protocol for a systematic review and network meta-analysis from the CIRCLE group. BMJ Open, 9 (10). ISSN 2044-6055

Neez, Emilie Marie Celine Anne, Hwang, Thomas, Sahoo, Samali Anova and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2019) European Medicines Agency’s Priority Medicines scheme at 2 years: an evaluation of clinical studies supporting eligible drugs. Clinical Pharmacology and Therapeutics, 107 (3). pp. 541-552. ISSN 0009-9236

Naci, Huseyin ORCID: 0000-0002-7192-5751, Davis, Courtney, Savović, Jelena, Higgins, Julian P. T., Sterne, Jonathan, Gyawali, Bishal, Romo Sandoval, Xochitl Citlalli, Handley, Nicola and Booth, Christopher M (2019) Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross-sectional analysis. BMJ, 366 (8214). ISSN 1756-1833

Athanasiou, Antonios, Veroniki, Areti Angeliki, Efthimiou, Orestis, Kalliala, Ilkka, Naci, Huseyin ORCID: 0000-0002-7192-5751, Bowden, Sarah, Paraskevaidi, Maria, Martin-Hirsch, Pierre, Bennett, Philip, Paraskevaidis, Evangelos, Salanti, Georgia and Kyrgiou, Maria (2019) Comparative efficacy and complication rates after local treatment for cervical intraepithelial neoplasia and stage 1a1 cervical cancer: protocol for a systematic review and network meta-analysis from the CIRCLE Group. BMJ Open, 9 (8). ISSN 2044-6055

Salcher-Konrad, Maximilian ORCID: 0000-0002-5628-5266, Naci, Huseyin ORCID: 0000-0002-7192-5751, McDaid, David ORCID: 0000-0003-0744-2664, Alladi, Suvarna, Oliveira, Déborah, Fry, Andra, Hussein, Shereen, Knapp, Martin ORCID: 0000-0003-1427-0215, Comas-Herrera, Adelina ORCID: 0000-0002-9860-9062, Musyimi, Christine, Ndetei, David and Lopez-Ortega, Mariana (2019) Effectiveness of interventions for dementia in low- and middle-income countries: protocol for a systematic review, pairwise and network meta-analysis. BMJ Open, 9 (6). ISSN 2044-6055

Hopkin, Gareth, Au, Anson, Collier, Verena Jane, Yudkin, John S, Basu, Sanjay and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2019) Combining multiple treatment comparisons with personalized patient preferences: a randomized trial of an interactive platform for statin treatment selection. Medical Decision Making, 39 (3). pp. 264-277. ISSN 0272-989X

Choi, Sung Eun, Berkowitz, Seth A., Yudkin, John S., Naci, Huseyin ORCID: 0000-0002-7192-5751 and Basu, Sanjay (2019) Personalizing second-line Type 2 diabetes treatment selection: combining network meta-analysis, individualized risk, and patient preferences for unified decision support. Medical Decision Making, 39 (3). pp. 239-252. ISSN 0272-989X

Naci, Huseyin ORCID: 0000-0002-7192-5751, Salcher-Konrad, Maximilian ORCID: 0000-0002-5628-5266, Mcguire, Alistair ORCID: 0000-0002-5367-9841, Berger, Felix, Kuehne, Titus, Goubergrits, Leonid, Muthurangu, Vivek, Wilson, Ben ORCID: 0000-0003-4274-617X and Kelm, Marcus (2019) Impact of predictive medicine on therapeutic decision making: a randomized controlled trial in congenital heart disease. npj Digital Medicine, 2 (1). ISSN 2398-6352

Naci, Huseyin ORCID: 0000-0002-7192-5751 and Dixon, Jennifer (2019) New agreement on branded drugs for the NHS. BMJ (Online), 364. p. 1266. ISSN 0959-8146

Naci, Huseyin ORCID: 0000-0002-7192-5751, Salcher-Konrad, Maximilian ORCID: 0000-0002-5628-5266, Dias, Sofia, Blum, Manuel R., Sahoo, Samali Anova, Nunan, David and Ioannidis, John P. A. (2018) How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 RCTs assessing exercise and medication effects on systolic blood pressure. British Journal of Sports Medicine. ISSN 0306-3674

Crispi, Francisca, Naci, Huseyin ORCID: 0000-0002-7192-5751, Barkauskaite, Eva, Osipenko, Leeza and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2018) Assessment of devices, diagnostics and digital technologies: a review of NICE medical technologies guidance. Applied Health Economics and Health Policy. ISSN 1175-5652

Anderson, Michael ORCID: 0000-0002-8454-4640, Naci, Huseyin ORCID: 0000-0002-7192-5751, Morrison, Deborah, Osipenko, Leeza and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2018) A review of NICE appraisals of pharmaceuticals 2000-2016 found variation in establishing comparative clinical effectiveness. Journal of Clinical Epidemiology. ISSN 0895-4356

Salanti, Georgia, Nikolakopoulou, Adriani, Sutton, Alex J., Reichenbach, Stephan, Trelle, Sven, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Egger, Matthias (2018) Planning a future randomized clinical trial based on a network of relevant past trials. Trials, 19 (365). ISSN 1745-6215

Wallach, Joshua D., Ross, Joseph S. and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2018) The US Food and Drug Administration’s expedited approval programs: Evidentiary standards, regulatory trade-offs, and potential improvements. Clinical Trials. ISSN 1740-7745

Wallach, Joshua D., Ross, Joseph S. and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2018) The US Food and Drug Administration’s expedited approval programs: addressing premarket flexibility with enhanced postmarket evidence generation. Clinical Trials, 15 (3). pp. 243-246. ISSN 1740-7745

Naci, Huseyin ORCID: 0000-0002-7192-5751, Vardas, Panos, Vahanian, Alec, Kirchhof, Paulus, Bardinet, Isabel and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2017) Training the next generation of cardiovascular leaders in health policy and economics. European Heart Journal, 38 (45). pp. 3332-3335. ISSN 0195-668X

Naci, Huseyin ORCID: 0000-0002-7192-5751 and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2017) Accelerated access to new drugs and technologies. BMJ, 359. pp. 1-2. ISSN 1756-1833

Naci, Huseyin ORCID: 0000-0002-7192-5751 (2017) What to do (or not to do) when randomization is not possible. Journal of Heart and Lung Transplantation, 36 (11). pp. 1174-1177. ISSN 1053-2498

Davis, Courtney, Naci, Huseyin ORCID: 0000-0002-7192-5751, Gurpinar, Evrim, Poplavska, Elita, Pinto, Ashlyn and Aggarwal, Ajay (2017) Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13. BMJ (359). ISSN 1756-1833

Wenzl, Martin, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2017) Health policy in times of austerity — a conceptual framework for evaluating effects of policy on efficiency and equity illustrated with examples from Europe since 2008. Health Policy, 121 (9). pp. 947-954. ISSN 0168-8510

Naci, Huseyin ORCID: 0000-0002-7192-5751, Smalley, Katelyn R. and Kesselheim, Aaron S. (2017) Characteristics of preapproval and postapproval studies for drugs granted accelerated approval by the US food and drug administration. JAMA, 318 (7). pp. 626-636. ISSN 0098-7484

Naci, Huseyin ORCID: 0000-0002-7192-5751, Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Gupta, Radhika and Ioannidis, John P. A. (2017) Timing and characteristics of cumulative evidence available on novel therapeutic agents receiving Food and Drug Administration accelerated approval. The Milbank Quarterly, 95 (2). 261 - 290. ISSN 0887-378X

Kaier, K., Reinecke, H., Naci, Huseyin ORCID: 0000-0002-7192-5751, Frankenstein, L., Bode, M., Vach, W., Hehn, P., Zirlik, A., Zehender, M. and Reinöhl, J. (2017) The impact of post-procedural complications on reimbursement, length of stay and mechanical ventilation among patients undergoing transcatheter aortic valve implantation in Germany. European Journal of Health Economics, 19 (2). pp. 223-228. ISSN 1618-7598

Naci, Huseyin ORCID: 0000-0002-7192-5751 (2016) Communication of treatment rankings obtained from network meta-­analysis using data visualization. Circulation: Cardiovascular Quality and Outcomes, 9 (5). pp. 605-608. ISSN 1941-7705

Olczak, Kaya, Salcher, Maximillian and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2016) What works best in congenital heart disease? Comparing two interventions for treatment of Aortic Coarctation. LSE Health and Social Care (02 Sep 2016). Website.

Dhutia, Harshil, Malhotra, Aneil, Gabus, Vincent, Merghani, Ahmed, Finocchiaro, Gherardo, Millar, Lynne, Narain, Rajay, Papadakis, Michael, Naci, Huseyin ORCID: 0000-0002-7192-5751, Tome, Maite and Sharma, Sanjay (2016) Cost implications of using different ECG criteria for screening young athletes in the United Kingdom. Journal of the American College of Cardiology, 68 (7). pp. 702-711. ISSN 0735-1097

Naci, Huseyin ORCID: 0000-0002-7192-5751 and Soumerai, Stephen B. (2016) History bias, study design, and the unfulfilled promise of pay-for-performance policies in health care. Preventing Chronic Disease, 13 (160133). pp. 1-7. ISSN 1545-1151

Salcher, Maximilian ORCID: 0000-0002-5628-5266, Naci, Huseyin ORCID: 0000-0002-7192-5751, Law, Tyler J., Kuehne, Titus, Schubert, Stephan and Kelm, Marcus (2016) Balloon dilatation and stenting for aortic coarctation: a systematic review and meta-analysis. Circulation: Cardiovascular Interventions. ISSN 1941-7640

Luyten, Jeroen, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Knapp, Martin ORCID: 0000-0003-1427-0215 (2016) Economic evaluation of mental health interventions: an introduction to cost-utility analysis. Evidence-Based Mental Health, 19. pp. 49-53. ISSN 1362-0347

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Samani, Nilesh J (2015) QALYs in cost-effectiveness analysis: an overview for cardiologists. Heart, 10 (23). pp. 1868-1873. ISSN 1355-6037

Naci, Huseyin ORCID: 0000-0002-7192-5751, Basu, Sanjay and Yudkin, John S (2015) Preventing cardiovascular events with empagliflozin: at what cost? The Lancet Diabetes and Endocrinology, 3 (12). p. 931. ISSN 2213-8587

Naci, Huseyin ORCID: 0000-0002-7192-5751, Carter, Alexander W. and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2015) Why the drug development pipeline is not delivering better medicines. BMJ, 351. ISSN 1756-1833

Tervonen, Tommi, Naci, Huseyin ORCID: 0000-0002-7192-5751, van Valkenhoef, Gert, Ades, Anthony E., Angelis, Aris ORCID: 0000-0002-0261-4634, Hillege, Hans L. and Postmus, Douwe (2015) Applying multiple criteria decision analysis to comparative benefit-risk assessment: choosing among statins in primary prevention. Medical Decision Making, 35 (7). pp. 859-871. ISSN 0272-989X

Naci, Huseyin ORCID: 0000-0002-7192-5751, Carter, Alexander W. and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2015) Double failure: the shared accountability of governments and firms for the innovation deficit in the pharmaceutical sector. BMJ. ISSN 1756-1833

Naci, Huseyin ORCID: 0000-0002-7192-5751 and Ioannidis, John P. A. (2015) Evaluation of wellness determinants and interventions by citizen scientists. JAMA, 314 (2). p. 121. ISSN 0098-7484

Mossialos, Elias ORCID: 0000-0001-8664-9297, Courtin, Emilie ORCID: 0009-0006-4656-2967, Naci, Huseyin ORCID: 0000-0002-7192-5751, Benrimoj, Shalom, Bouvy, Marcel, Farris, Karen, Noyce, Peter and Sketris, Ingrid (2015) From "retailers" to health care providers: transforming the role of community pharmacists in chronic disease management. Health Policy, 119 (5). pp. 628-639. ISSN 0168-8510

Naci, Huseyin ORCID: 0000-0002-7192-5751 and Ioannidis, John P. A. (2015) How good is "Evidence" from clinical studies of drug effects and why might such evidence fail in the prediction of clinical utility of drugs. Annual Review of Pharmacology and Toxicology, 55. pp. 169-189. ISSN 0362-1642

Naci, Huseyin ORCID: 0000-0002-7192-5751, Spackman, Eldon and Fleurence, Rachael (2015) National approaches to comparative effectiveness research. In: Sobolev, Boris, (ed.) Handbook of Health Services Research. Springer reference. Springer Berlin / Heidelberg, Berlin, Germany. ISBN 9781461446569

Naci, Huseyin ORCID: 0000-0002-7192-5751, Lehman, Richard, Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Goldacre, Ben and Yudkin, John S (2015) Rethinking the appraisal and approval of drugs for type 2 diabetes. BMJ, 351 (h5260). ISSN 1756-1833

Naci, Huseyin ORCID: 0000-0002-7192-5751, Cooper, Jacob and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2015) Timely publication and sharing of trial data: opportunities and challenges for comparative effectiveness research in cardiovascular disease. European Heart Journal - Quality of Care and Clinical Outcomes. ISSN 2058-5225

Chambers, James D., Naci, Huseyin ORCID: 0000-0002-7192-5751, Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Pyo, Junhee, Gunjal, Shalak, Kennedy, Ian R., Hoey, Mark G., Winn, Aaron and Neumann, Peter J. (2015) An assessment of the methodological quality of published network meta-analyses: a systematic review. PLOS ONE, 10 (4). ISSN 1932-6203

Naci, Huseyin ORCID: 0000-0002-7192-5751 (2014) Does industry sponsorship bias research findings? Health and Social Care at LSE (21 Oct 2014). Website.

Naci, Huseyin ORCID: 0000-0002-7192-5751, Dias, Sofia and Ades, A. E. (2014) Industry sponsorship bias in research findings: a network meta-analysis of LDL cholesterol reduction in randomised trials of statins. BMJ, 349 (oct03). g5741-g5741. ISSN 1756-1833

Naci, Huseyin ORCID: 0000-0002-7192-5751 and Alexander, George Caleb (2014) Regulators should better leverage effectiveness standards to enhance drug value. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 34 (10). pp. 1005-1011. ISSN 0277-0008

Naci, Huseyin ORCID: 0000-0002-7192-5751, van Valkenhoef, G., Higgins, J. P. T., Fleurence, R. and Ades, A. E. (2014) Evidence-based prescribing: combining network meta-analysis with multicriteria decision analysis to choose among multiple drugs. Circulation: Cardiovascular Quality and Outcomes, 7 (5). pp. 787-792. ISSN 1941-7705

Naci, Huseyin ORCID: 0000-0002-7192-5751, Soumerai, Stephen B, Ross-Degnan, Dennis, Zhang, Fang, Briesacher, Becky A., Gurwitz, Jerry H. and Madden, Jeanne M. (2014) Medication affordability gains following Medicare Part D are eroding among elderly with multiple chronic conditions. Health Affairs, 33 (8). pp. 1435-1443. ISSN 0278-2715

Naci, Huseyin ORCID: 0000-0002-7192-5751 (2014) Persistent medication affordability problems among disabled medicare beneficiaries after Part D, 2006-2011. Medical Care, 52 (11). pp. 951-956. ISSN 0025-7079

Naci, Huseyin ORCID: 0000-0002-7192-5751 and O’Connor, Alec B (2013) Assessing comparative effectiveness of new drugs before approval using prospective network meta-analyses. Journal of Clinical Epidemiology, 66 (8). pp. 812-816. ISSN 0895-4356

Naci, Huseyin ORCID: 0000-0002-7192-5751, Brugts, Jasper Jan, Fleurence, Rachael and Ades, Anthony E. (2013) Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials. European Journal of Preventive Cardiology, 20 (4). pp. 658-670. ISSN 2047-4873

Naci, Huseyin ORCID: 0000-0002-7192-5751, Brugts, Jasper Jan and Ades, Tony (2013) Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials. Circulation: Cardiovascular Quality and Outcomes, 6 (4). pp. 390-399. ISSN 1941-7705

Jansen, Jeroen P. and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2013) Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers. BMC Medicine, 11 (1). p. 159. ISSN 1741-7015

Mossialos, Elias ORCID: 0000-0001-8664-9297, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Courtin, Emilie ORCID: 0009-0006-4656-2967 (2013) Expanding the role of community pharmacists: policymaking in the absence of policy-relevant evidence? Health Policy, 111 (2). pp. 135-148. ISSN 0168-8510

Naci, Huseyin ORCID: 0000-0002-7192-5751, Brugts, Jasper Jan, Fleurence, Rachael and Ades, Anthony E. (2013) Comparative effects of statins on major cerebrovascular events: a multiple-treatments meta-analysis of placebo-controlled and active-comparator trials. QJM - Monthly Journal of the Association of Physicians, 106 (4). pp. 299-306. ISSN 1460-2725

Rahmioglu, Nilufer, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Cylus, Jonathan ORCID: 0000-0001-8269-1578 (2012) Improving health care services in Northern Cyprus: a call for research and action. European Journal of Public Health, 22 (6). pp. 754-755. ISSN 1101-1262

Winter, H.S., Mossialos, E. ORCID: 0000-0001-8664-9297, Naci, Huseyin ORCID: 0000-0002-7192-5751, Chandra, A., Salojee, H., Yamashiro, Y., Bhutta, Z.A., Uauy, R. and Corvalan, C. (2012) The economics of health care delivery. Journal of Pediatric Gastroenterology and Nutrition, 55 (5). pp. 482-488. ISSN 0277-2116

Naci, Huseyin ORCID: 0000-0002-7192-5751 and Cylus, Jonathan ORCID: 0000-0001-8269-1578 (2012) Why a stricter regulation of drugs could foster (not deter) pharmaceutical innovation. British Politics and Policy at LSE (21 Sep 2012). Website.

Naci, Huseyin ORCID: 0000-0002-7192-5751, Cylus, Jonathan ORCID: 0000-0001-8269-1578, Vandoros, Sotiris, Sato, Azusa and Perampaladas, Kumar (2012) Raising the bar for market authorisation of new drugs. The BMJ, 345. e4261-e4261. ISSN 1756-1833

Naci, Huseyin ORCID: 0000-0002-7192-5751, de Lissovoy, Gregory, Hollenbeak, Christopher, Custer, Brian, Hofmann, Axel, McClellan, William and Gitlin, Matthew (2012) Historical clinical and economic consequences of anemia management in patients with end-stage renal disease on dialysis using erythropoietin stimulating agents versus routine blood transfusions: a retrospective cost-effectiveness analysis. Journal of Medical Economics, 15 (2). pp. 293-304. ISSN 1369-6998

Chisholm, Daniel, Naci, Huseyin ORCID: 0000-0002-7192-5751, Hyder, Adnan Ali, Tran, Nhan T. and Peden, Margie (2012) Cost effectiveness of strategies to combat road traffic injuries in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ, 344 (mar02). e612-e612. ISSN 0959-8146

Naci, Huseyin ORCID: 0000-0002-7192-5751 and Fleurence, Rachael (2011) Using indirect evidence to determine the comparative effectiveness of prescription drugs: do benefits outweigh risks? Health Outcomes Research in Medicine, 2 (4). e241-e249. ISSN 1877-1319

Sorenson, Corinna, Naci, Huseyin ORCID: 0000-0002-7192-5751, Cylus, Jonathan ORCID: 0000-0001-8269-1578 and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2011) Evidence of comparative efficacy should have a formal role in European drug approvals. British Medical Journal, 343 (7822). d4849-d4849. ISSN 0959-8138

Naci, Huseyin ORCID: 0000-0002-7192-5751 (2011) The increasing need to harmonize evidence demands of regulators, payers, and health technology assessment bodies in Europe – opportunities and challenges. ISPOR Connections, 17 (4). pp. 4-6. ISSN 1538-5108

Fleurence, Rachel L., Naci, Huseyin ORCID: 0000-0002-7192-5751 and Jansen, Jeroen P. (2010) The critical role of observational evidence in comparative effectiveness research. Health Affairs, 29 (10). pp. 1826-1833. ISSN 0278-2715

McIntyre, Roger S., Cragin, Lael, Sorensen, Sonja, Naci, Huseyin ORCID: 0000-0002-7192-5751, Baker, Tim and Roussy, Jean-Pascal (2010) Comparison of the metabolic and economic consequences of long-term treatment of schizophrenia using ziprasidone, olanzapine, quetiapine and risperidone in Canada: a cost-effectiveness analysis. Journal of Evaluation in Clinical Practice, 16 (4). pp. 744-755. ISSN 1356-1294

Naci, Huseyin ORCID: 0000-0002-7192-5751, Fleurence, Rachael, Birt, Julie and Duhig, Amy (2010) Economic burden of multiple sclerosis. PharmacoEconomics, 28 (5). pp. 363-379. ISSN 1170-7690

Naci, Huseyin ORCID: 0000-0002-7192-5751, Fleurence, Rachael, Birt, Julie and Duhig, Amy (2010) The impact of increasing neurological disability of multiple sclerosis on health utilities: a systematic review of the literature. Journal of Medical Economics, 13 (1). pp. 78-89. ISSN 1369-6998

Chisholm, Dan and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2008) Road traffic injury prevention: an assessment of risk exposure and intervention cost-effectiveness in different world regions. HSF discussion papers. World Health Organization, Geneva, Switzerland.

Naci, Huseyin ORCID: 0000-0002-7192-5751 and Baker, Timothy D. (2008) Productivity losses from road traffic deaths in Turkey. International Journal of Injury Control and Safety Promotion, 15 (1). pp. 19-24. ISSN 1745-7300

Naci, Huseyin ORCID: 0000-0002-7192-5751, Leontsini, Elli and Baker, Timothy D. (2007) One island, two parts, shared aspirations. Harvard Health Policy Review, Fall (2). pp. 108-110. ISSN 1533-774X